Agilent Technologies, Inc. (LON:0HAV)
London
· Delayed Price · Currency is GBP · Price in USD 145.52
-2.62 (-1.77%)
At close: Dec 5, 2025
Revenue Breakdown
Fiscal year is November - October.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2012 - 2020 |
|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | 2012 - 2020 |
| Life Sciences & Diagnostics Markets Revenue | 2.73B |
Log In |
Log In |
Log In | Upgrade
|
| Agilent CrossLab Revenue (Post-FY2024 Reporting) | 2.91B |
Log In |
Log In |
Log In | Upgrade
|
| Applied Markets Revenue | 1.31B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 6.95B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is November - October.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2012 - 2020 |
|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | 2012 - 2020 |
| Life Sciences & Applied Markets Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics & Genomics Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| Agilent CrossLab Revenue (Pre-FY2025 Reporting) | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 6.95B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is November - October.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2012 - 2020 |
|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | 2012 - 2020 |
| Life Sciences & Diagnostics Markets Income from Operations | 536.00M |
Log In |
Log In |
Log In | Upgrade
|
| Agilent CrossLab Income from Operations (Post-FY2024 Reporting) | 946.00M |
Log In |
Log In |
Log In | Upgrade
|
| Applied Markets Income from Operations | 301.00M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | -304.00M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 1.48B |
Log In |
Log In |
Log In | Upgrade
|
EBIT 2
Fiscal year is November - October.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2012 - 2020 |
|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | 2012 - 2020 |
| Life Sciences & Applied Markets Income from Operations | - |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics & Genomics Income from Operations | - |
Log In |
Log In |
Log In | Upgrade
|
| Agilent CrossLab Income from Operations (Pre-FY2025 Reporting) | - |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 1.48B |
Log In |
Log In |
Log In | Upgrade
|